1. Home
  2. LION vs BEAM Comparison

LION vs BEAM Comparison

Compare LION & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$9.18

Market Cap

2.4B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.99

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LION
BEAM
Founded
1997
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LION
BEAM
Price
$9.18
$27.99
Analyst Decision
Buy
Strong Buy
Analyst Count
10
12
Target Price
$9.11
$48.09
AVG Volume (30 Days)
2.9M
1.6M
Earning Date
02-05-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,858,000,000.00
$55,701,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$22.30
$26.52
P/E Ratio
N/A
N/A
Revenue Growth
21.18
N/A
52 Week Low
$5.55
$13.53
52 Week High
$9.25
$35.25

Technical Indicators

Market Signals
Indicator
LION
BEAM
Relative Strength Index (RSI) 76.84 60.09
Support Level $8.21 $26.17
Resistance Level $9.25 $28.29
Average True Range (ATR) 0.43 1.35
MACD 0.09 0.07
Stochastic Oscillator 92.52 78.58

Price Performance

Historical Comparison
LION
BEAM

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: